2、 Polymer molecules with multiple elements whose activities replace the interaction of the eighth coagulation factor (FVII) and pharmaceutical formulations containing the element as an active ingredient

• 收藏
• 分享

专利权人:

CHUGAI SEIYAKU KABUSHIKI KAISHA

发明人:

SOEDA, TETSUHIRO,YAMAGUCHI, KAZUKI,IGAWA, TOMOYUKI,KOGA, HIKARU,KATO, KAZUKI,TERANISHI, YURI

申请号：

ARP180102782

公开号：

AR113142A1

申请日:

2018.09.27

申请国别(地区):

AR

年份:

2020

代理人:

摘要：

2. For the two antibodies, the inhibition and activation activity (the ninth factor of blood coagulation) of pentabromodiphenyl ether is not high, and the substitution activity of FVII is high. Methods: nucleic acid, cell, drug formulation.Anticuerpos biespecíficos cuya actividad inhibidora de activación de FIX (factor IX de coagulación sanguínea) no es elevada y cuya actividad de sustitución de la función de cofactor FVIII es elevada. Método, ácido nucleico, célula, formulación farmacéutica.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/